ACET Adicet Bio, Inc.

Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cells therapies for cancer and other diseases.

$13.70
As of 03/05/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Other
USA
USA
01/26/2018
19,600,567
257,962
$268,527,768
7.43%
SEC Edgar Online
10-Q
10-K
007002108
US0070021086
BMC5RV6

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-9.09
2.30
-66.81
-36.08%
1,049.86%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy